Ignite Creation Date:
2025-12-25 @ 4:10 AM
Ignite Modification Date:
2025-12-26 @ 3:08 AM
Study NCT ID:
NCT00676520
Status:
COMPLETED
Last Update Posted:
2012-11-20
First Post:
2007-10-16
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA-Phase 1)
Sponsor:
Abbott Medical Devices
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-07
Start Date Type:
None
Primary Completion Date:
2011-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-03
Completion Date Type:
ACTUAL
First Submit Date:
2007-10-16
First Submit QC Date:
None
Study First Post Date:
2008-05-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-06-07
Results First Submit QC Date:
None
Results First Post Date:
2012-11-20
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-10-10
Last Update Post Date:
2012-11-20
Last Update Post Date Type:
ESTIMATED